Here are five insights:
1. Adin develops, manufactures and sells products and services in the dental field, offering technological solutions to customers worldwide.
2. The licensing agreement identifies three major dental applications for DSG, estimating a potential for 8 million dental procedures.
3. Other terms of the agreement include technology transfer, product development support, milestones and royalty payments.
4. Pierre Jérôme, CEO and co-founder of SpineGuard, said, “This licensing agreement is a big step forward for SpineGuard as it demonstrates the potential for our DSG technology beyond spine surgery.”
5. Eyal Milman, CEO and co-founder of Adin, said, “This collaboration with SpineGuard is an important step toward making this innovative technology accessible to Adin’s patients and [physicians].”
More articles on devices and implants:
Global orthopedic devices market to hit $58.8B by 2023 – 8 observations
Medtronic, DePuy Synthes, Smith & Nephew & more: 14 device company key notes
Zimmer Biomet introduces X-PSI Knee System – 5 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
